Patent · US Expired

Lyxofuranosyl analogues of adenosine

US5506347A · kind A · utility

115Cited by
0References
51Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 1994
Grant dateApr 9, 1996
Priority date
Expiry dateFeb 3, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel lyxose derivatives which selectively inhibit adenosine kinase and methods of preparing these compounds are provided. These compounds are useful in treating certain conditions in vivo which may be ameliorated by increased local concentrations of adenosine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.